Daewon Pharmaceutical has launched a liquid allergy treatment aimed at conditions including rhinitis and conjunctivitis.
The company said on the 5th that it had released Coldaewon Lergitoc Liquid, a liquid-form allergy treatment that can also be taken by children who have difficulty swallowing tablets. The product is an over-the-counter medicine used for seasonal and perennial allergic rhinitis, allergic conjunctivitis and chronic idiopathic urticaria.
The liquid formulation can be taken by children aged 2 and older and comes in individually packaged 5-milliliter aluminum foil pouches for easy portability. Daewon Pharmaceutical has relaunched its existing Lergientoc Liquid under the Coldaewon family brand, extending the lineup into allergy treatments alongside Coldaewon Kids, its cold medicine for children.
